Cargando…

Predicting Alzheimer's disease development: a comparison of cognitive criteria and associated neuroimaging biomarkers

INTRODUCTION: The definition of “objective cognitive impairment” in current criteria for mild cognitive impairment (MCI) varies considerably between research groups and clinics. This study aims to compare different methods of defining memory impairment to improve prediction models for the developmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Callahan, Brandy L., Ramirez, Joel, Berezuk, Courtney, Duchesne, Simon, Black, Sandra E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634913/ https://www.ncbi.nlm.nih.gov/pubmed/26537709 http://dx.doi.org/10.1186/s13195-015-0152-z

Ejemplares similares

Dynamic Progression of White Matter Hyperintensities in Alzheimer’s Disease and Normal Aging: Results from the Sunnybrook Dementia Study
por: Ramirez, Joel, et al.
Publicado: (2016)

Cognitive and Neuroimaging Profiles of Older Adults With Attention Deficit/Hyperactivity Disorder Presenting to a Memory Clinic
por: Callahan, Brandy L., et al.
Publicado: (2021)

Editorial: Neuroimaging Biomarkers and Cognition in Alzheimer's Disease Spectrum
por: Chen, Jiu, et al.
Publicado: (2022)

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
por: Ramirez, Joel, et al.
Publicado: (2014)

Neuroimaging Biomarkers for Alzheimer’s Disease
por: Márquez, Freddie, et al.
Publicado: (2019)

Interactions Between Neuropsychiatric Symptoms and Alzheimer's Disease Neuroimaging Biomarkers in Predicting Longitudinal Cognitive Decline
por: Pink, Anna, et al.
Publicado: (2023)

Neuroimage Biomarker Identification of the Conversion of Mild Cognitive Impairment to Alzheimer’s Disease
por: Kung, Te-Han, et al.
Publicado: (2021)

Structural Neuroimaging of Concomitant Depressive Symptoms in Amnestic Mild Cognitive Impairment: A Pilot Study
por: Morin, Jean-François, et al.
Publicado: (2012)

Prediction of Alzheimer's Pathological Changes in Subjective Cognitive Decline Using the Self-report Questionnaire and Neuroimaging Biomarkers
por: Hong, Yun Jeong, et al.
Publicado: (2019)

Longitudinal Cognitive Performance of Older Adults With ADHD Presenting to a Cognitive Neurology Clinic: A Case Series of Change Up to 21 Years
por: Callahan, Brandy L., et al.
Publicado: (2021)

Correlation of plasma and neuroimaging biomarkers in Alzheimer's disease
por: Brickman, Adam M., et al.
Publicado: (2022)

Multimodal MRI Neuroimaging Biomarkers for Cognitive Normal Adults, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease
por: Lin, Ai-Ling, et al.
Publicado: (2012)

Neuroimaging criteria and cognitive performance in vascular mild cognitive impairment: A systematic review
por: Sudo, Felipe Kenji, et al.
Publicado: (2015)

Association of peripheral immunity with cognition, neuroimaging, and Alzheimer’s pathology
por: Hou, Jia-Hui, et al.
Publicado: (2022)

Neuroimaging Biomarkers Predicting the Efficacy of Multimodal Rehabilitative Intervention in the Alzheimer’s Dementia Continuum Pathology
por: Di Tella, Sonia, et al.
Publicado: (2021)

High-Dimensional Medial Lobe Morphometry: An Automated MRI Biomarker for the New AD Diagnostic Criteria
por: Duchesne, Simon, et al.
Publicado: (2014)

Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts
por: Cao, Lei, et al.
Publicado: (2016)

Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers
por: Nho, Kwangsik, et al.
Publicado: (2019)

Neuroimaging biomarkers of cognitive recovery after ischemic stroke
por: Tahmi, Mouna, et al.
Publicado: (2022)

Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer’s disease: a systematic review
por: Ruan, Qingwei, et al.
Publicado: (2016)

Association between NME8 Locus Polymorphism and Cognitive Decline, Cerebrospinal Fluid and Neuroimaging Biomarkers in Alzheimer's Disease
por: Liu, Ying, et al.
Publicado: (2014)

Detection of β-amyloid positivity in Alzheimer’s Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers
por: Tosun, Duygu, et al.
Publicado: (2021)

Assessment of the quality of brain regions and neuroimaging metrics as biomarkers of Alzheimer’s Disease
por: Vaz, Tânia Faria, et al.
Publicado: (2015)

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
por: Wang, Xiaoqi, et al.
Publicado: (2020)

Inexpensive, non-invasive biomarkers predict Alzheimer transition using machine learning analysis of the Alzheimer’s Disease Neuroimaging (ADNI) database
por: Beltrán, Juan Felipe, et al.
Publicado: (2020)

Identification of prognostic factors to predict cognitive decline of patients with early Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative study
por: Yagi, Takuya, et al.
Publicado: (2019)

An interpretable Alzheimer’s disease oligogenic risk score informed by neuroimaging biomarkers improves risk prediction and stratification
por: Suh, Erica H., et al.
Publicado: (2023)

Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative
por: Canevelli, Marco, et al.
Publicado: (2020)

Clinical and cognitive characteristics of preclinical Alzheimer's disease in the Japanese Alzheimer's Disease Neuroimaging Initiative cohort
por: Ihara, Ryoko, et al.
Publicado: (2018)

Bias-adjustment in neuroimaging-based brain age frameworks: A robust scheme
por: Beheshti, Iman, et al.
Publicado: (2019)

Alzheimer’s Disease Diagnosis: Discrepancy between Clinical, Neuroimaging, and Cerebrospinal Fluid Biomarkers Criteria in an Italian Cohort of Geriatric Outpatients: A Retrospective Cross-sectional Study
por: Dolci, Giulia A. M., et al.
Publicado: (2017)

Characterizing heterogeneity in the progression of Alzheimer's disease using longitudinal clinical and neuroimaging biomarkers
por: Goyal, Devendra, et al.
Publicado: (2018)

Transfer Learning for Alzheimer’s Disease through Neuroimaging Biomarkers: A Systematic Review
por: Agarwal, Deevyankar, et al.
Publicado: (2021)

Predicting episodic memory performance using different biomarkers: results from Argentina-Alzheimer’s Disease Neuroimaging Initiative
por: Russo, María Julieta, et al.
Publicado: (2016)

The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
por: Ba, Maowen, et al.
Publicado: (2017)

Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study
por: Mosconi, Lisa, et al.
Publicado: (2014)

Adult ADHD: Risk Factor for Dementia or Phenotypic Mimic?
por: Callahan, Brandy L., et al.
Publicado: (2017)

Biomarkers Predicting Alzheimer's Disease in Cognitively Normal Aging
por: Shim, Yong S., et al.
Publicado: (2011)

Cognition and Neuroimaging in Schizophrenia
por: Calhoun, Vince D., et al.
Publicado: (2012)

Neuroimaging Biomarkers Predict Brain Structural Connectivity Change in a Mouse Model of Vascular Cognitive Impairment
por: Boehm-Sturm, Philipp, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8tusbe677kqrr7tdosp4rc0shu